Document Classification

Section Type: RESULTS

Text: During follow-up, there were no differences between the groups assigned 2. 5 mg or 7. 5 mg oral insulin or placebo in subcutaneous insulin requirements, haemoglobin A1c concentrations, or measurements of fasting (mean at 12 months 0. 18 [SD 0. 17], 0. 17 [0. 17], and 0. 17 [0. 12] nmol/L) or stimulated C-peptide concentrations (glucagon-stimulated 0. 39 [0. 38], 0. 37 [0. 39], and 0. 33 [0. 24] nmol/L ; meal-stimulated 0. 72 [0. 60], 0. 49 [0. 49], and 0. 57 [0. 51 nmol/L].